Duchenne muscular dystrophin (DMD)

Clinical trials for Duchenne muscular dystrophin (DMD) explained in plain language.

Never miss a new study

Get alerted when new Duchenne muscular dystrophin (DMD) trials appear

Sign up with your email to follow new studies for Duchenne muscular dystrophin (DMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

CRISPR therapy shows promise in early trial for fatal muscle disease

Disease control Ongoing

This early-phase study tested a new gene editing treatment called HG302 in 4 boys with Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. The therapy uses CRISPR technology to fix the genetic error and help muscles produce dystrophin, a protein essential for musc…

Matched conditions: DUCHENNE MUSCULAR DYSTROPHIN (DMD)

Early phase 1 • Sponsor: HuidaGene Therapeutics Co., Ltd. • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

Duchenne muscular dystrophin (DMD)

Get alerted when new Duchenne muscular dystrophin (DMD) trials appear

CRISPR therapy shows promise in early trial for fatal muscle disease